Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

NYSEARCA:ELA - NYSE Arca - US29402E1029 - Common Stock - Currency: USD

6.6  -0.09 (-1.35%)

Fundamental Rating

6

Taking everything into account, ELA scores 6 out of 10 in our fundamental rating. ELA was compared to 120 industry peers in the Specialty Retail industry. Both the health and profitability get an excellent rating, making ELA a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, ELA is valued expensive at the moment. This makes ELA very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ELA had positive earnings in the past year.
In the past year ELA had a positive cash flow from operations.
Each year in the past 5 years ELA has been profitable.
Of the past 5 years ELA 4 years had a positive operating cash flow.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

1.2 Ratios

The Return On Assets of ELA (8.36%) is better than 80.34% of its industry peers.
With a decent Return On Equity value of 12.65%, ELA is doing good in the industry, outperforming 69.23% of the companies in the same industry.
ELA's Return On Invested Capital of 9.36% is fine compared to the rest of the industry. ELA outperforms 71.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELA is above the industry average of 12.30%.
The last Return On Invested Capital (9.36%) for ELA is well below the 3 year average (14.39%), which needs to be investigated, but indicates that ELA had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.36%
ROE 12.65%
ROIC 9.36%
ROA(3y)16.23%
ROA(5y)14.94%
ROE(3y)29.13%
ROE(5y)29.71%
ROIC(3y)14.39%
ROIC(5y)13.95%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

With a decent Profit Margin value of 3.83%, ELA is doing good in the industry, outperforming 73.50% of the companies in the same industry.
ELA's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 4.66%, ELA is in the better half of the industry, outperforming 63.25% of the companies in the same industry.
ELA's Operating Margin has improved in the last couple of years.
ELA has a Gross Margin of 25.43%. This is in the lower half of the industry: ELA underperforms 75.21% of its industry peers.
In the last couple of years the Gross Margin of ELA has grown nicely.
Industry RankSector Rank
OM 4.66%
PM (TTM) 3.83%
GM 25.43%
OM growth 3Y-5.04%
OM growth 5Y31.87%
PM growth 3Y-9.43%
PM growth 5Y27.9%
GM growth 3Y6.22%
GM growth 5Y6.27%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELA is still creating some value.
ELA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ELA has been reduced compared to 5 years ago.
Compared to 1 year ago, ELA has an improved debt to assets ratio.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ELA has an Altman-Z score of 7.34. This indicates that ELA is financially healthy and has little risk of bankruptcy at the moment.
ELA's Altman-Z score of 7.34 is amongst the best of the industry. ELA outperforms 96.58% of its industry peers.
The Debt to FCF ratio of ELA is 2.83, which is a good value as it means it would take ELA, 2.83 years of fcf income to pay off all of its debts.
ELA has a better Debt to FCF ratio (2.83) than 71.79% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that ELA is not too dependend on debt financing.
ELA has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.83
Altman-Z 7.34
ROIC/WACC0.94
WACC10%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

ELA has a Current Ratio of 4.76. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.76, ELA belongs to the best of the industry, outperforming 96.58% of the companies in the same industry.
A Quick Ratio of 2.08 indicates that ELA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.08, ELA belongs to the best of the industry, outperforming 90.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.76
Quick Ratio 2.08
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

5

3. Growth

3.1 Past

ELA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
Measured over the past years, ELA shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.37% on average per year.
Looking at the last year, ELA shows a decrease in Revenue. The Revenue has decreased by -7.47% in the last year.
The Revenue has been growing by 26.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-42.86%
EPS 3Y3.97%
EPS 5Y61.37%
EPS Q2Q%0%
Revenue 1Y (TTM)-7.47%
Revenue growth 3Y14.65%
Revenue growth 5Y26%
Sales Q2Q%29.32%

3.2 Future

Based on estimates for the next years, ELA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.83% on average per year.
ELA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.22% yearly.
EPS Next Y-10.65%
EPS Next 2Y17.43%
EPS Next 3Y15.83%
EPS Next 5YN/A
Revenue Next Year-2.94%
Revenue Next 2Y1.58%
Revenue Next 3Y7.22%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.50 indicates a quite expensive valuation of ELA.
ELA's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. ELA is around the same levels.
With a Price/Forward Earnings ratio of 18.41, ELA is valued on the expensive side.
ELA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ELA is cheaper than 64.10% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ELA to the average of the S&P500 Index (22.68), we can say ELA is valued inline with the index average.
Industry RankSector Rank
PE 27.5
Fwd PE 18.41
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ELA.
ELA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 35.09
EV/EBITDA 18
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The decent profitability rating of ELA may justify a higher PE ratio.
A more expensive valuation may be justified as ELA's earnings are expected to grow with 15.83% in the coming years.
PEG (NY)N/A
PEG (5Y)0.45
EPS Next 2Y17.43%
EPS Next 3Y15.83%

0

5. Dividend

5.1 Amount

ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENVELA CORP

NYSEARCA:ELA (2/21/2025, 8:15:32 PM)

6.6

-0.09 (-1.35%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)03-19 2025-03-19/amc
Inst Owners12.96%
Inst Owner Change-96.52%
Ins Owners50.07%
Ins Owner Change0.05%
Market Cap171.60M
Analysts80
Price Target8.16 (23.64%)
Short Float %1.67%
Short Ratio5.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.66%
Min EPS beat(2)18.81%
Max EPS beat(2)48.51%
EPS beat(4)3
Avg EPS beat(4)14.75%
Min EPS beat(4)-23.84%
Max EPS beat(4)48.51%
EPS beat(8)5
Avg EPS beat(8)25.14%
EPS beat(12)8
Avg EPS beat(12)24.53%
EPS beat(16)12
Avg EPS beat(16)28.95%
Revenue beat(2)2
Avg Revenue beat(2)22%
Min Revenue beat(2)21.16%
Max Revenue beat(2)22.84%
Revenue beat(4)3
Avg Revenue beat(4)9.11%
Min Revenue beat(4)-15.42%
Max Revenue beat(4)22.84%
Revenue beat(8)5
Avg Revenue beat(8)2.48%
Revenue beat(12)9
Avg Revenue beat(12)8.01%
Revenue beat(16)11
Avg Revenue beat(16)6.21%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)10.84%
EPS NY rev (3m)10.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.22%
Valuation
Industry RankSector Rank
PE 27.5
Fwd PE 18.41
P/S 1.02
P/FCF 35.09
P/OCF 19.45
P/B 3.36
P/tB 3.97
EV/EBITDA 18
EPS(TTM)0.24
EY3.64%
EPS(NY)0.36
Fwd EY5.43%
FCF(TTM)0.19
FCFY2.85%
OCF(TTM)0.34
OCFY5.14%
SpS6.49
BVpS1.97
TBVpS1.66
PEG (NY)N/A
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 8.36%
ROE 12.65%
ROCE 11.81%
ROIC 9.36%
ROICexc 12.76%
ROICexgc 15.23%
OM 4.66%
PM (TTM) 3.83%
GM 25.43%
FCFM 2.9%
ROA(3y)16.23%
ROA(5y)14.94%
ROE(3y)29.13%
ROE(5y)29.71%
ROIC(3y)14.39%
ROIC(5y)13.95%
ROICexc(3y)19.21%
ROICexc(5y)18.51%
ROICexgc(3y)23.95%
ROICexgc(5y)23.17%
ROCE(3y)18.37%
ROCE(5y)17.88%
ROICexcg growth 3Y-11.04%
ROICexcg growth 5Y17.27%
ROICexc growth 3Y-11.2%
ROICexc growth 5Y13.58%
OM growth 3Y-5.04%
OM growth 5Y31.87%
PM growth 3Y-9.43%
PM growth 5Y27.9%
GM growth 3Y6.22%
GM growth 5Y6.27%
F-Score6
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.83
Debt/EBITDA 1.38
Cap/Depr 270.36%
Cap/Sales 2.33%
Interest Coverage 15.75
Cash Conversion 94.69%
Profit Quality 75.62%
Current Ratio 4.76
Quick Ratio 2.08
Altman-Z 7.34
F-Score6
WACC10%
ROIC/WACC0.94
Cap/Depr(3y)174.01%
Cap/Depr(5y)271.65%
Cap/Sales(3y)1.23%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y3.97%
EPS 5Y61.37%
EPS Q2Q%0%
EPS Next Y-10.65%
EPS Next 2Y17.43%
EPS Next 3Y15.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.47%
Revenue growth 3Y14.65%
Revenue growth 5Y26%
Sales Q2Q%29.32%
Revenue Next Year-2.94%
Revenue Next 2Y1.58%
Revenue Next 3Y7.22%
Revenue Next 5YN/A
EBIT growth 1Y-25.59%
EBIT growth 3Y8.86%
EBIT growth 5Y66.15%
EBIT Next Year1.96%
EBIT Next 3Y20.02%
EBIT Next 5YN/A
FCF growth 1Y-46.86%
FCF growth 3Y51.7%
FCF growth 5Y81.29%
OCF growth 1Y-7.17%
OCF growth 3Y-5.38%
OCF growth 5Y73.17%